Meeder Advisory Services Inc. Makes New $1.17 Million Investment in Kenvue Inc. $KVUE

Meeder Advisory Services Inc. purchased a new stake in shares of Kenvue Inc. (NYSE:KVUE) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 61,369 shares of the company’s stock, valued at approximately $1,173,000.

Several other hedge funds have also made changes to their positions in the company. Calamos Advisors LLC lifted its stake in Kenvue by 24.1% in the 1st quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock worth $57,771,000 after acquiring an additional 651,000 shares in the last quarter. State of Wyoming grew its stake in Kenvue by 233.5% during the 4th quarter. State of Wyoming now owns 97,992 shares of the company’s stock valued at $1,690,000 after acquiring an additional 68,609 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its stake in Kenvue by 21.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock valued at $60,229,000 after acquiring an additional 618,720 shares in the last quarter. Cullen Frost Bankers Inc. increased its holdings in shares of Kenvue by 19.9% in the 4th quarter. Cullen Frost Bankers Inc. now owns 431,394 shares of the company’s stock valued at $7,442,000 after purchasing an additional 71,591 shares during the period. Finally, Cibc World Market Inc. increased its holdings in shares of Kenvue by 8.7% in the 4th quarter. Cibc World Market Inc. now owns 744,290 shares of the company’s stock valued at $12,839,000 after purchasing an additional 59,723 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on KVUE. Wall Street Zen cut shares of Kenvue from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. UBS Group dropped their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Finally, Barclays lifted their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue currently has an average rating of “Hold” and an average target price of $19.27.

Kenvue Stock Performance

Shares of KVUE stock opened at $19.16 on Thursday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $21.84. The stock’s 50-day moving average is $19.02 and its two-hundred day moving average is $18.18. The firm has a market cap of $36.80 billion, a P/E ratio of 22.02, a PEG ratio of 1.35 and a beta of 0.47.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). The firm had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.29 earnings per share. Analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, August 12th. This is a boost from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 annualized dividend and a yield of 4.4%. Kenvue’s payout ratio is 96.55%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.